2 days agoNews ArticlesAdditional Price Cuts to Insulin are on the WaySeveral drug manufacturers have announced price cuts on commonly prescribed insulin products. By Brock Bizzell and David Baker | Original...
5 days agoNews ArticlesJeffrey Casberg Predicts Generic, Biosimilar Competition in the Pharmaceutical MarketJeffrey Casberg, RPh, MS, examines upcoming generic and biosimilar competition in the pharmaceutical industry, showcasing certain drugs...
Apr 22News ArticlesAMCP 2024: Key Takeaways From Leading SpeakersIPD Analytics speaks about key takeaways from the AJMC 2024 Annual Conference
Apr 18News ArticlesGene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?IPD presents at the AMCP 2024 annual meeting discussing the current promise and future potential of gene and cell therapies.
Apr 18News ArticlesPotential Generics Could Lower Prices for Oncology, Cardiovascular Drugs | AMCP 2024IPD Analytics LLC. discusses the up to 50 generics that could be approved this year, including Victoza to treat patients with diabetes.